To identify and target the key events in the alterations of immunogenicity and response to immunotherapies in metastatic melanomas resistant to targeted therapies.
Importe
0,00 €
To identify and target the key events in the alterations of immunogenicity and response to immunotherapies in metastatic melanomas resistant to targeted therapies.